Open access · OA via Europe PMC

Cell Reprogramming: Therapeutic Advances and Challenges

Li A, Wang Z, Lyu Z, Tuo Z, Li X, Wu R, Wang J, Wusiman D, Wang Y, Zhang Q, Xiong W, Zhou B, Feng D.

Research (Washington, D.C.)

Stem-cell exhaustion Partial reprogramming (OSK)

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
Canonical: link ↗
Fetched: 2026-11-12 MST

Cite this

APA

A, L., Z, W., Z, L., Z, T., X, L., R, W., J, W., D, W., Y, W., Q, Z., W, X., B, Z., & D., F. (n.d.). Cell Reprogramming: Therapeutic Advances and Challenges. <em>Research (Washington, D.C.)</em>. https://europepmc.org/article/PMC/PMC13748628

Vancouver

A L, Z W, Z L, Z T, X L, R W, et al. Cell Reprogramming: Therapeutic Advances and Challenges. Research (Washington, D.C.).

BibTeX

@article{lindCellRe, title = {Cell Reprogramming: Therapeutic Advances and Challenges}, author = {Li A and Wang Z and Lyu Z and Tuo Z and Li X and Wu R and Wang J and Wusiman D and Wang Y and Zhang Q and Xiong W and Zhou B and Feng D.}, journal = {Research (Washington, D.C.)}, }